ReviewClinical and translational science2024

Crushing tablets or sprinkling capsules: Implications for clinical strategy and study performance based on BE studies of rivaroxaban and deferasirox.

Jan Sus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.